申请人:Sandoz, Inc.
公开号:US04180671A1
公开(公告)日:1979-12-25
Dibenz[c,f]imidazo [1,2-a] [1]azepin-9-ols of the general formula ##STR1## where R.sub.1 represents H or mono or di-chloro or fluoro, and R.sub.2 represents H, chloro, fluoro, alkyl of 1-3 carbon atoms, e.g., methyl, ethyl or isopropyl, alkoxy of 1-3 carbon atoms, e.g., methoxy or ethoxy, or trifluoromethyl, prepared by borohydride hydrogenation of the corresponding 9-ones are useful as anti-convulsant agents.
通式为 ##STR1## 的二苯并[c,f]咪唑[1,2-a][1]氮杂环庚醇,其中R.sub.1代表氢,单氯,双氯或氟,R.sub.2代表氢,氯,氟,1-3碳原子的烷基,例如甲基,乙基或异丙基,1-3碳原子的烷氧基,例如甲氧基或乙氧基,或三氟甲基。通过对应的9-酮进行硼氢化氢化反应制备的化合物可用作抗惊厥剂。